Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Transcatheter Aortic Valve Replacement Market, and What Factors Will Drive It?
In the past few years, the market size for transcatheter aortic valve replacement has seen a swift expansion. The market is projected to increase from $5.19 billion in 2024 to $5.87 billion in 2025, with a compound annual growth rate (CAGR) of 13.2%. This significant growth during the historical period is due to factors such as the escalating occurrences of aortic regurgitation and cardiovascular diseases, a higher preference among patients for less invasive treatment methods, worldwide expansion of TAVR procedures, and supportive reimbursement policies.
The market for transcatheter aortic valve replacement is projected to expand rapidly in the coming years, reaching a value of $9.99 billion in 2029 with an annual compound growth rate of 14.2%. This predicted growth during the forecasted timeframe can be associated with increased instances of aortic stenosis, wider acceptance of minimally invasive procedures, broader implications for TAVR procedures, beneficial reimbursement approaches, and growing recognition of TAVR as a potential treatment option. Key trends to watch during this forecast period encompass the constant evolution of device technology, increased occurrence of cardiovascular illnesses, worldwide proliferation of TAVR procedures, a growing aged population, and escalating healthcare spending.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp
Which Primay Drivers Are Accelerating Growth in the Transcatheter Aortic Valve Replacement Market?
The upward trend in the instances of aortic stenosis is credited as a key catalyst propelling the transcatheter aortic valve replacement market in future. Essentially, aortic stenosis is a health issue that implies the contraction of the aortic valve in the heart. Transcatheter aortic valve replacement (TAVR), a treatment approach that is not as invasive as surgical aortic valve replacement (SAVR), is utilized in addressing this problem. It helps in reestablishing blood circulation and reducing the indicators and effects of aortic valve stenosis. For instance, the American Heart Association, a non-profit organization in the US, released data in May 2024 indicating that over 12% of senior Americans are suffering from aortic stenosis, a condition often found in those aged above 65. If this condition is overlooked, it could lead to heart failure and possibly death. Moreover, a report from the UK-based public organization, the National Institute for Health and Care Excellence (NICE), in March 2023, stated that around 1.5% of the UK population above 55, roughly 300,000, are dealing with severe aortic stenosis. From this, almost 200,000 have the symptomatic disease that requires treatment. This contributes to over 380,000 individuals on cardiac waiting lists by March 2023. Thus, the surge in instances of aortic stenosis is promoting the transcatheter aortic valve replacement market.
Which Primary Segments of the Transcatheter Aortic Valve Replacement Market Are Driving Growth and Industry Transformations?
The transcatheter aortic valve replacementmarket covered in this report is segmented –
1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12031&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Transcatheter Aortic Valve Replacement Market?# Market?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Transcatheter Aortic Valve Replacement Industry Dynamics?
Trend 1 emphasizes the importance of product innovation in the transcatheter aortic valve replacement (TAVR) arena. The key players in this sector are striving to devise highly innovative and tech-advanced solutions to assert their dominance in this competitive market. For instance, Edwards Lifesciences, a well-established medical technology firm based in the US, unveiled its Sapien 3 Ultra Resilia valve in Europe in May 2024. This launch marked the introduction of the only transcatheter aortic valve replacement (TAVR) system encompassing the firm’s signature Resilia tissue tech. The unique technology is aimed at boosting the lifespan of the valve, applies anti-calcification treatment to bovine pericardial tissue. By adding this technology that inhibits calcium, the Resilia framework assists in reducing structural valve damage, a predominant reason for reintervention following valve replacement.
View the full report here:
What Parameters Are Used to Define the Transcatheter Aortic Valve Replacement Market?
Transcatheter aortic valve replacement (TAVR), also known as transcatheter aortic valve implantation (TAVI), is a minimally invasive medical procedure used to replace a diseased or malfunctioning aortic valve in the heart. It can be performed on adults who are not in good enough health to undergo standard valve surgery.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12031
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model